Elite Pharmaceuticals, Inc. ELTP OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

65/100

2/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Elite Pharmaceuticals, Inc. (ELTP) .

이 페이지에서 입증된 기준:

VALUE (0/100, 미달) — 종합 밸류에이션 점수가 통과에 필요한 60/100 기준 미만입니다.

SharesGrow 종합 점수: 61/100 2/7 개 기준 통과.

SharesGrow 7-Criteria Score

65/100

SG Score

View full scorecard →

—

가치

N/A

No coverage

—

미래

N/A

No coverage

과거

75/100

→ Income

✓

재무건전

100/100

Debt-to-Equity & liquidity

→ Health

✗

해자

39/100

→ Income

✓

성장

100/100

→ Income

✗

수익

10/100

→ Income

밸류에이션 개요 — ELTP

밸류에이션 배수

P/E (TTM)0.0

선행 P/EN/A

PEG 비율N/A

선행 PEGN/A

P/B 비율0.00

P/S 비율4.83

EV/EBITDA0.0

주당 데이터

EPS (TTM)$0.00

주당 장부가치$0.00

주당 매출$0.08

주당 FCF$0.00

수익률 & 적정가치

이익 수익률N/A

배당 수익률0.00%

EPS: 실적 vs 추정

P/E Ratio & Earnings Yield

주당순이익 (EPS) 추이

Year	EPS (희석)	매출	순이익	순이익률
2016	$0.00	$12.5M	$-683.01K	-5.5%
2017	$-0.01	$9.64M	$3.81M	39.5%
2018	$0.00	$7.46M	$-3.67M	-49.2%
2019	$-0.01	$7.57M	$-9.28M	-122.6%
2020	$0.00	$17.99M	$-2.24M	-12.5%
2021	$0.01	$25.38M	$5.09M	20%
2022	$0.01	$32.26M	$8.9M	27.6%
2023	$4.35	$34.16B	$4.41B	12.9%
2024	$0.02	$56.63M	$20.11M	35.5%
2025	$0.00	$84.04M	$-4.31M	-5.1%